Global Study Manager

AstraZeneca•Durham, NC

1d•Hybrid

About The Position

The Global Study Manager is a member of the extended global study team supporting delivery of clinical studies within BioPharmaceuticals Clincal Operations, Study Management to time, cost and quality, from Clinical Study Protocol (CSP) development through study set-up, maintenance, close-out, development of Clinical Study Report (CSR) to study archiving. The GSM works cross-functionally with internal and external partners to deliver delegated aspects of the clinical study in accordance with Global Study Director (GSD) or Global Study Associate Director (GSAD) in delegated aspects of clinical study execution in accordance with the Delivery Model, AZ Project Management Framework, current clinical trial regulations (e.g. ICH GCP), AstraZeneca Standard Operating Procedures (AZ SOPs), AZ policies and standard methodologies (e.g. AZ guidelines) and in line with AZ values and behaviours.

Requirements

Bachelor’s degree with 5 years of experience
Prior experience supporting senior leaders in a fast-paced company setting
Strong interpersonal skills
Experience in establishing and maintaining collaboration across senior leaders’ community
Proficient in oral and written English and with excellent communication skills
Proven track record to develop knowledge in relation to business processes
Experience using Planisware (PLANIT) at the portfolio level, including extracting data and managing portfolio views

Responsibilities

Portfolio narrative, analytics, and reporting
Own the portfolio narrative linking strategy, achievements, risks, and resourcing to enable Senior Executive Team planning and prioritization
Maintain a forward-looking Hematology portfolio slide deck and deliver the monthly portfolio slide update (Portfolio Updates, Scorecard Goal Tracker, GPL Roster Changes, etc.)
Manage ad hoc slide updates with the Internal Communications Director and External Congress Director
Consolidate Hematology abstract views, aligning content across programs and congresses, ensuring consistency of messages
Run the Haem Project Seminar Series in collaboration with Global Project Leads to keep stakeholders up to date on the evolving Hematology portfolio, coordinating speakers, content, and follow-up material
Portfolio planning, reviews, and GPT readiness
Lead annual portfolio reviews including discovery portfolio review (Haematology Discovery Days), clinical portfolio review, and scorecard goal planning
Coordinate and execute ad hoc Hematology Portfolio Reviews with relevant stakeholders and decision makers, including face-to-face reviews as needed
Review monthly workload distribution to ensure balanced assignment of Global Project Leaders
Ensure Global Project Leaders and Global Project Managers are assigned at least three months before Lead Optimization review at the Oncology Research Board
Maintain a forward-looking governance interaction list for the Hematology R&D Leadership Team
Lead ad hoc portfolio information validation requests, coordinating with program teams to ensure data accuracy and alignment with governance standards
Hematology Project Advisory Board (HPAB)
Serve as HPAB Secretariat
Develop and maintain the forward agenda aligned to portfolio milestones and governance needs
Run the end-to-end process including pre-reads, surveys, timekeeping, decision capture, action tracking, and next-step ownership
Continuously evolve scope and ways of working as the portfolio grows
Innovation, ways of working, and business cycle
Explore AI and new technologies to improve portfolio analytics and ways of working, partnering with GPPM and Oncology Portfolio Managers to pilot and scale
Support VP of Projects and Haem Projects Group on GPT effectiveness initiatives and ad hoc tasks, including prompt libraries, workflow integration, and training
Support the annual business cycle to demonstrate portfolio growth and advocate for FTE growth in collaboration with BPO, Finance, and capacity owners